Answers are grounded in this paper and cite their sources.
Background Pulmonary hypoplasia remains one of the leading causes of mortality and severe respiratory failure in newborns with congenital diaphragmatic hernia and other developmental lung disorders. Although advances in neonatal intensive care and extracorporeal membrane oxygenation (ECMO) have substantially improved survival, current therapeutic strategies remain almost exclusively supportive and do not directly promote lung growth. Increasing evidence indicates that physiological hypoxia is not merely tolerated during fetal life but acts as a fundamental developmental signal regulating pulmonary vascular growth and alveolar maturation through hypoxia-sensitive pathways, particularly the HIF-VEGF axis. Main body Building upon this developmental framework, we propose a novel hypothesis whereby ECMO may, for the first time, provide the physiological conditions required to dissociate systemic oxygenation from pulmonary oxygen exposure. During ECMO, the newborn would be ventilated with a hypoxic gas mixture while adequate systemic oxygen delivery is maintained by extracorporeal gas exchange. We term this strategy hypoxic ventilation . Rather than inducing systemic hypoxemia, hypoxic ventilation aims to recreate, within the lung, the oxygen environment under which fetal pulmonary development normally occurs. We further hypothesize that, because a markedly reduced vascular bed characterizes the hypoplastic lung, its limited perfusion may attenuate oxygen delivery from the pulmonary circulation, allowing it to remain relatively more hypoxic than the better-perfused contralateral lung despite normal systemic oxygenation. This physiological condition may preferentially reactivate hypoxia-dependent developmental signaling exactly where pulmonary vascular growth is most needed. We further discuss how pharmacological amplification of these pathways, particularly through selective β 3 -adrenoceptor agonism, could enhance pulmonary angiogenesis and lung growth. Conclusion This perspective proposes a new biological interpretation of ECMO that extends beyond conventional organ support. If experimentally validated, hypoxic ventilation could transform ECMO from a bridge to survival into a developmental platform capable of restoring developmental oxygen signaling and promoting postnatal lung growth in pulmonary hypoplasia.
No takes yet. Share an insight, caveat, or question.
Filippi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: